Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG

NCT00037713 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

515

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Small Cell Lung

Interventions

BIOLOGICAL: BEC2 Vaccine

Sponsor

Eli Lilly and Company

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]